Home LiteratureArticle Details
PMID: 14745008 Published · ppublish English Journal Article

Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors.

Hawari FI, Rouhani FN, Cui X, Yu ZX, Buckley C, Kaler M, Levine SJ

Abstract

Soluble tumor necrosis factor receptors (TNFRs) are important modulators of TNF bioactivity. Proteolytic cleavage of the 28-kDa ectodomain of TNFR1 has been recognized as the mechanism by which soluble TNFR is shed. We now describe the release of exosome-like vesicles as a mechanism for the generation of soluble, full-length 55-kDa TNFR1. We found unexpectedly that the predominant form of soluble TNFR1 in human serum and lung epithelial lining fluid is a full-length 55-kDa protein. Furthermore, supernatants from human vascular endothelial cells contain only full-length 55-kDa TNFR1 that can be sedimented by high-speed centrifugation, floated on sucrose gradients at a density of 1.1 g/ml, and associated with vesicles that range in diameter from 20 nm to 50 nm. We conclude that the release of TNFR1 exosome-like vesicles represents a previously unrecognized mechanism by which constitutive production of soluble cytokine receptors may be regulated, independent of ectodomain cleavage by receptor sheddases.

MeSH Terms
Antigens, CD/analysis,blood,metabolism Catalysis Endothelial Cells/chemistry Epithelium/chemistry Humans Lung/chemistry Membrane Microdomains/chemistry Metalloproteases/physiology Receptors, Tumor Necrosis Factor/analysis,blood,metabolism Receptors, Tumor Necrosis Factor, Type I Tumor Necrosis Factor-alpha/metabolism
Chemicals
Antigens, CD Receptors, Tumor Necrosis Factor Receptors, Tumor Necrosis Factor, Type I Tumor Necrosis Factor-alpha Metalloproteases
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Hawari Feras I
Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Rouhani Farshid N
Cui Xinle
Yu Zu-Xi
Buckley Caitriona
Kaler Maryann
Levine Stewart J
References (26)
26 references, click to expand
  1. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.
    Blood. 1999 Dec 1;94(11):3791-9 PMID: 10572093
  2. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.
    J Clin Invest. 1999 Jul;104(1):93-102 PMID: 10393703
  3. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device.
    J Cell Sci. 2000 Oct;113 Pt 19:3365-74 PMID: 10984428
  4. Rapid secretion of interleukin-1beta by microvesicle shedding.
    Immunity. 2001 Nov;15(5):825-35 PMID: 11728343
  5. TNF-R1 signaling: a beautiful pathway.
    Science. 2002 May 31;296(5573):1634-5 PMID: 12040173
  6. Exosomes: composition, biogenesis and function.
    Nat Rev Immunol. 2002 Aug;2(8):569-79 PMID: 12154376
  7. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding.
    J Clin Invest. 2002 Aug;110(4):515-26 PMID: 12189246
  8. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation.
    Immunity. 2003 May;18(5):655-64 PMID: 12753742
  9. Histamine antagonizes tumor necrosis factor (TNF) signaling by stimulating TNF receptor shedding from the cell surface and Golgi storage pool.
    J Biol Chem. 2003 Jun 13;278(24):21751-60 PMID: 12646554
  10. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.
    Cell. 2003 Jul 25;114(2):181-90 PMID: 12887920
  11. Isolation and characterization of a tumor necrosis factor binding protein from urine.
    Eur J Haematol. 1989 Mar;42(3):270-5 PMID: 2924890
  12. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor.
    J Biol Chem. 1989 Jul 15;264(20):11966-73 PMID: 2545692
  13. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.
    J Biol Chem. 1989 Jul 15;264(20):11974-80 PMID: 2545693
  14. Molecular cloning and expression of a receptor for human tumor necrosis factor.
    Cell. 1990 Apr 20;61(2):361-70 PMID: 2158863
  15. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.
    EMBO J. 1990 Oct;9(10):3269-78 PMID: 1698610
  16. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.
    J Biol Chem. 1991 Sep 25;266(27):18324-9 PMID: 1655744
  17. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
    J Exp Med. 1992 Feb 1;175(2):323-9 PMID: 1310100
  18. Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor.
    J Biol Chem. 1994 Dec 23;269(51):32488-96 PMID: 7798250
  19. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells.
    Am J Pathol. 1995 Jan;146(1):27-32 PMID: 7856733
  20. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.
    J Immunol. 1995 Dec 1;155(11):5198-205 PMID: 7594530
  21. B lymphocytes secrete antigen-presenting vesicles.
    J Exp Med. 1996 Mar 1;183(3):1161-72 PMID: 8642258
  22. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.
    J Clin Invest. 1997 Apr 1;99(7):1546-54 PMID: 9119998
  23. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes.
    J Biol Chem. 1998 Aug 7;273(32):20121-7 PMID: 9685355
  24. TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1.
    J Immunol. 1999 Jan 15;162(2):1042-8 PMID: 9916731
  25. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains.
    Science. 1999 Jan 22;283(5401):543-6 PMID: 9915703
  26. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.
    J Biol Chem. 2000 May 12;275(19):14608-14 PMID: 10799547
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2004-02-03
Epub
2004-00-26
Pages
1297-302
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC337047
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com